Pompano Beach, Sept. 19, 2013 (GLOBE NEWSWIRE) -- DS Healthcare Group, NASDAQ (DSKX) announced today that Daniel Khesin, DS Healthcare's CEO, will present at the at the Aegis Capital Corporation 2013 Healthcare Conference on Saturday, September 28, 2013 at 11:00 AM PDT. The conference will be held at the Encore at Wynn Las Vegas on September 26-28, 2013.
About DS Healthcare Group
DS Healthcare Group Inc. leads in the development and distribution of topical therapies for personal care, including what management believes is the world's most effective topical treatment for hair loss. Its products are sold through a network of salons, pharmacies, online retailers, specialty retailers and select department stores. Its brands include DS Laboratories(www.DSLaboratories.com), Sigma Skin (www.(www.SigmaSkin.com), Polaris Research Laboratories (www.PolarisResearchLabs.com) The Pure Guild (www.ThePureGuild.com) and Nutra Origin (www.NutraOrigin.com)
Forward-looking statements
Except for statements of historical fact, the matters discussed in this press release are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies, and are generally preceded by words such as "future," "plan" or "planned," "expects," or "projected." These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company's control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history, difficulty in developing and marketing products, intense competition, and additional risks factors as discussed in reports filed by the company with the Securities and Exchange Commission, which are available at http://www.sec.gov.